27 Jan 2020
We are happy to announce that Beo Therapeutics has been chosen as a Top 60 startup by the W.A. De Vigier Stiftung.
We are happy to announce that Beo Therapeutics has been chosen as a Top 60 startup by the W.A. De Vigier Stiftung.
15 Jan 2020
Beo Therapeutics will present at the Sachs European Life Sciences CEO Forum, 19-20 February 2020, Zurich, Switzerland as part of the the Rising Star Showcase. Rikke C Nielsen will be presenting at 14:30 on 20 Feb 2020.
Beo Therapeutics will present at the Sachs European Life Sciences CEO Forum, 19-20 February 2020, Zurich, Switzerland as part of the the Rising Star Showcase. Rikke C Nielsen will be presenting at 14:30 on 20 Feb 2020.
5 Dec 2019
Beo Therapeutics has been invited to give an oral presentation at the 7th Microbiome R&D & Business Collaboration Forum, taking place on 18th – 20th May 2020 in Rotterdam, The Netherlands.
Beo Therapeutics has been invited to give an oral presentation at the 7th Microbiome R&D & Business Collaboration Forum, taking place on 18th – 20th May 2020 in Rotterdam, The Netherlands.
14 Nov 2019
Beo Therapeutics is happy to be selected by Venturelab to join the Food Scale Up Day on November 26th. The event is a great opportunity to connect with industry leaders from the Swiss food industry.
Beo Therapeutics is happy to be selected by Venturelab to join the Food Scale Up Day on November 26th. The event is a great opportunity to connect with industry leaders from the Swiss food industry.
3 Nov 2019
Beo Therapeutics has been invited to give an oral presentation and join panel discussion at the 4th annual Microbiome Movement – Drug Development Europe in London on 4-6 Feb 2020.
Presentation: Optimising the Gut Microbiome to Rebalance Urate Metabolism and Pre-empt Hyperuricemia.
Panel Discussion: The Borderline Between Pharma and Food – How is the Microbiome Blurring the Lines?
Beo Therapeutics has been invited to give an oral presentation and join panel discussion at the 4th annual Microbiome Movement – Drug Development Europe in London on 4-6 Feb 2020.
Presentation: Optimising the Gut Microbiome to Rebalance Urate Metabolism and Pre-empt Hyperuricemia.
Panel Discussion: The Borderline Between Pharma and Food – How is the Microbiome Blurring the Lines?